135 related articles for article (PubMed ID: 5626106)
21. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
Yamakido M; Yokoyama M; Noguchi S
Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
[No Abstract] [Full Text] [Related]
22. [Biological determination of thyrotropin and long-acting thyroid simulator].
Potin VV; Stepanov GS
Probl Endokrinol (Mosk); 1969; 15(4):64-7. PubMed ID: 5395630
[No Abstract] [Full Text] [Related]
23. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
Studer H
Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
[No Abstract] [Full Text] [Related]
24. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
25. Familial incidence of long-acting thyroid stimulator (LATS) in Graves' disease.
Bonnyns M; Vanhaelst L
Horm Metab Res; 1972 Mar; 4(2):132. PubMed ID: 5067566
[No Abstract] [Full Text] [Related]
26. Pituitary-thyroid function in thyrotoxic patients in relation to long-acting thyroid stimulator (LATS) levels.
Fukuchi M; Matsuoka T; Inoue T; Miyai K; Kumahara Y
Acta Endocrinol (Copenh); 1970 Dec; 65(4):577-82. PubMed ID: 5536685
[No Abstract] [Full Text] [Related]
27. [The etiopathogenic role of long-acting thyroid stimulator in thyrotoxicosis].
Papazov G; Milanov S; Platonova E
Vutr Boles; 1972; 11(2):59-62. PubMed ID: 4679953
[No Abstract] [Full Text] [Related]
28. [Etiology of hyperthyroidism].
Lemarchand-Béraud T; Vannotti A; Griessen M
Schweiz Med Wochenschr; 1967 Oct; 97(41):1342-52. PubMed ID: 5631864
[No Abstract] [Full Text] [Related]
29. The value of IgG separation for the detection of LATS in human serum.
Bonnyns M; Vanhaelst L
Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
[TBL] [Abstract][Full Text] [Related]
30. Rational management of thyroid auto-immune disease.
Adams DD
N Z Med J; 1974 Dec; 80(529):486-9. PubMed ID: 4141486
[No Abstract] [Full Text] [Related]
31. [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].
Ziemke A; Weisbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W
Klin Wochenschr; 1968 Oct; 46(19):1025-7. PubMed ID: 5727481
[No Abstract] [Full Text] [Related]
32. [Etiopathogenesis of thyrotoxicosis].
de Medeiros Neto GA
Rev Paul Med; 1967 Jan; 70(1):48-52. PubMed ID: 5631892
[No Abstract] [Full Text] [Related]
33. Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.
Adams DD; Kennedy TH; Stewart JC; Utiger RD; Vidor GI
J Clin Endocrinol Metab; 1975 Aug; 41(2):221-8. PubMed ID: 51028
[TBL] [Abstract][Full Text] [Related]
34. [Non-fatal case of neonatal thyrotoxicosis with serial determination of LATS].
Tsuji A; Koshimizu T; Kato K
Horumon To Rinsho; 1970 May; 18(5):417-20. PubMed ID: 5465536
[No Abstract] [Full Text] [Related]
35. [LATS(long-acting thyroid stimulator): recent development].
Shishiba Y
Naika; 1971; 28(1):48-52. PubMed ID: 4935654
[No Abstract] [Full Text] [Related]
36. [Recent advances in studies on LATS].
Kumahara U; Miyai K; Fukuchi M
Saishin Igaku; 1967 Jul; 22(7):1373-80. PubMed ID: 4171439
[No Abstract] [Full Text] [Related]
37. Relation between thyroid function and serum levels of long-acting thyroid stimulator.
Davis JC; Hipkin LJ; Summers VK; Gimlette TM
Acta Endocrinol (Copenh); 1975 Jul; 79(3):451-8. PubMed ID: 1173501
[TBL] [Abstract][Full Text] [Related]
38. [The TRH stimulation test in hyperthyroid patients following prolonged therapy with thiocarbamides].
Martino E; Pinchera A; Loi AM; Romaldini JH; Fenzi GF; Baschieri L
Folia Endocrinol; 1974 Feb; 27(1):117-22. PubMed ID: 4219355
[No Abstract] [Full Text] [Related]
39. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
Strumia E
Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
[No Abstract] [Full Text] [Related]
40. [Relation between the exophthalmos producing factor (EPF) and thyroid antibodies].
Kreysing G; Schemmel K; Weisbecker L; Uthgenannt H; Müller W; Kirmse L
Schweiz Med Wochenschr; 1968 Jun; 98(23):852-4. PubMed ID: 5666557
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]